Barrington Research Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $14
Benzinga Newsdesk 2 months ago
NewsInitiationAnalyst RatingsPrice Target
Barrington Research initiates coverage on Viemed Healthcare (NASDAQ:VMD) with a Outperform rating and announces Price Target of $14.
Barrington Research initiates coverage on Viemed Healthcare (NASDAQ:VMD) with a Outperform rating and announces Price Target of $14.